Coya Therapeutics Inc
NASDAQ:COYA
| Market Cap (Intraday) | 98.58M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $6.31 |
| 50-Day MA | $6.23 |
| 200-Day MA | $6.08 |
Coya Therapeutics Inc Stock, NASDAQ:COYA
5850 San Felipe Street, Suite 500, Houston, Texas 77057
United States of America
Phone: +1.800.587.8170
Number of Employees: 8
Description
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.